CN1233417C - 肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物 - Google Patents

肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物 Download PDF

Info

Publication number
CN1233417C
CN1233417C CNB95197680XA CN95197680A CN1233417C CN 1233417 C CN1233417 C CN 1233417C CN B95197680X A CNB95197680X A CN B95197680XA CN 95197680 A CN95197680 A CN 95197680A CN 1233417 C CN1233417 C CN 1233417C
Authority
CN
China
Prior art keywords
peptide
val
iddm
diabetes
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB95197680XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1175214A (zh
Inventor
伊伦·R·科恩
戴娜·埃利亚斯
马提蒂亚胡·弗里德金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1233417(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of CN1175214A publication Critical patent/CN1175214A/zh
Application granted granted Critical
Publication of CN1233417C publication Critical patent/CN1233417C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNB95197680XA 1994-12-21 1995-12-20 肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物 Expired - Lifetime CN1233417C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL112094 1994-12-21
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
IL114460 1995-07-05

Publications (2)

Publication Number Publication Date
CN1175214A CN1175214A (zh) 1998-03-04
CN1233417C true CN1233417C (zh) 2005-12-28

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB95197680XA Expired - Lifetime CN1233417C (zh) 1994-12-21 1995-12-20 肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物

Country Status (31)

Country Link
EP (1) EP0820303B1 (enExample)
JP (2) JP3420245B2 (enExample)
KR (1) KR100400480B1 (enExample)
CN (1) CN1233417C (enExample)
AR (1) AR002949A1 (enExample)
AT (1) ATE242005T1 (enExample)
AU (1) AU707835B2 (enExample)
BR (1) BR9510102A (enExample)
CA (1) CA2208274C (enExample)
CZ (1) CZ293784B6 (enExample)
DE (2) DE820303T1 (enExample)
DK (1) DK0820303T3 (enExample)
ES (1) ES2201137T3 (enExample)
FI (1) FI118373B (enExample)
HR (1) HRP950612B1 (enExample)
HU (1) HU224160B1 (enExample)
IL (1) IL116499A0 (enExample)
IS (1) IS1966B (enExample)
MX (1) MX9704738A (enExample)
NO (1) NO317350B1 (enExample)
NZ (1) NZ301440A (enExample)
PL (1) PL184145B1 (enExample)
PT (1) PT820303E (enExample)
RO (1) RO116777B1 (enExample)
RS (1) RS49517B (enExample)
SI (1) SI0820303T1 (enExample)
TR (1) TR199501630A2 (enExample)
TW (1) TW496872B (enExample)
UA (1) UA42040C2 (enExample)
UY (1) UY24130A1 (enExample)
WO (1) WO1996019236A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
EP1718158B1 (en) * 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
RU2282453C2 (ru) * 2004-12-14 2006-08-27 Александр Борисович Смолянинов Способ терапии больных сахарным диабетом ii типа
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
EP1858545A2 (en) * 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
CA2609667C (en) 2005-05-25 2011-02-22 Curedm, Inc. Human proislet peptide, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en) 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
US8816047B2 (en) 2007-08-30 2014-08-26 Cure DM Group Holdings, LLC Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
ATE242005T1 (de) 2003-06-15
IS4510A (is) 1997-06-19
NO972849D0 (no) 1997-06-19
MX9704738A (es) 1997-10-31
CA2208274C (en) 2005-12-06
YU78795A (sh) 1998-05-15
ES2201137T3 (es) 2004-03-16
DE820303T1 (de) 1999-05-20
HUT78092A (hu) 1999-09-28
JP3554319B2 (ja) 2004-08-18
EP0820303B1 (en) 2003-06-04
SI0820303T1 (en) 2003-10-31
EP0820303A1 (en) 1998-01-28
AR002949A1 (es) 1998-05-27
JP2004026797A (ja) 2004-01-29
PL184145B1 (pl) 2002-09-30
HU224160B1 (hu) 2005-06-28
PT820303E (pt) 2003-10-31
JPH10511649A (ja) 1998-11-10
NO972849L (no) 1997-08-13
FI972669L (fi) 1997-08-15
AU4686696A (en) 1996-07-10
KR100400480B1 (ko) 2003-12-31
HRP950612A2 (en) 1997-10-31
IS1966B (is) 2004-12-15
DK0820303T3 (da) 2003-10-06
HRP950612B1 (en) 2003-12-31
PL321091A1 (en) 1997-11-24
RS49517B (sr) 2006-10-27
TW496872B (en) 2002-08-01
TR199501630A2 (tr) 1996-07-21
FI972669A0 (fi) 1997-06-19
AU707835B2 (en) 1999-07-22
WO1996019236A1 (en) 1996-06-27
DE69531004T2 (de) 2004-02-05
FI118373B (fi) 2007-10-31
NO317350B1 (no) 2004-10-18
RO116777B1 (ro) 2001-06-29
CN1175214A (zh) 1998-03-04
CZ293784B6 (cs) 2004-07-14
NZ301440A (en) 2000-01-28
UA42040C2 (uk) 2001-10-15
CA2208274A1 (en) 1996-06-27
JP3420245B2 (ja) 2003-06-23
IL116499A0 (en) 1996-03-31
UY24130A1 (es) 1996-06-11
BR9510102A (pt) 1997-11-25
EP0820303A4 (enExample) 1998-03-11
DE69531004D1 (de) 2003-07-10
CZ190897A3 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
CN1233417C (zh) 肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物
CN1102598C (zh) 由人热激蛋白60衍生的新型肽类及其组合物和应用
CN1150030C (zh) 重组人甲胎蛋白及其用途
CN1209876A (zh) 分离的酪氨酸酶衍生肽及其应用
CN1154144A (zh) 酪氨酸酶衍生的分离肽及其应用
CN1191091C (zh) 新型免疫疾病预防剂/治疗剂
CN101065398A (zh) Hsp60的肽和apl型衍生物及药物组合物
CN1227263C (zh) 用于自身免疫性疾病的诊断及治疗的肽
CN1393557A (zh) 一种多肽——人含肽基脯氨酸顺反异构酶特征性序列片段的蛋白－14.08和编码这种多肽的多核苷酸
CN1352176A (zh) 一种新的多肽——人大蛋白54.78和编码这种多肽的多核苷酸
CN1352189A (zh) 一种新的多肽——人大蛋白35.64和编码这种多肽的多核苷酸
CN1381485A (zh) 一种多肽——人大蛋白－27.28和编码这种多肽的多核苷酸
CN1358766A (zh) 一种新的多肽——人富含亮氨酸、脯氨酸的蛋白聚糖44和编码这种多肽的多核苷酸
CN1359911A (zh) 一种新的多肽——铁调节蛋白38.39和编码这种多肽的多核苷酸
CN1345838A (zh) 一种新的多肽——人含核糖体蛋白S24e特征性序列片段的蛋白9.68和编码这种多肽的多核苷酸
CN1345942A (zh) 一种新的多肽——人含吡啶核苷酸二硫键氧化还原酶ι级活性位点蛋白10.34和编码这种多肽的多核苷酸
HK1024006B (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
CN1376707A (zh) 一种多肽——人锌指蛋白－35.09和编码这种多肽的多核苷酸
CN1382725A (zh) 一种多肽——人大蛋白－45.76和编码这种多肽的多核苷酸
CN1381467A (zh) 一种多肽——人锌指蛋白－32.56和编码这种多肽的多核苷酸
CN1381466A (zh) 一种多肽——人锌指蛋白－26.84和编码这种多肽的多核苷酸
CN1363673A (zh) 一种新的多肽——人线粒体天冬氨酸转氨酶9.46和编码这种多肽的多核苷酸
CN1359954A (zh) 一种新的多肽——人大蛋白78和编码这种多肽的多核苷酸
CN1345880A (zh) 一种新的多肽——人大蛋白51.59和编码这种多肽的多核苷酸
CN1342759A (zh) 一种新的多肽——人逆转录酶12.76和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20051228

EXPY Termination of patent right or utility model